Experiment summary for ENCSR975JXS

doi:10.17989/ENCSR975JXS

Summary

Status
released
Assay
Mint-ChIP-seq
Target
H3K4me1
Biosample summary
Homo sapiens T-helper 1 cell male adult (35 years) treated with 1 μg/mL Interleukin-4 antibody for 36 hours, 30 ng/mL Interleukin-12 subunit alpha for 36 hours, 30 ng/mL Interleukin-12 subunit beta for 36 hours
Biosample Type
primary cell
Replication type
unreplicated
Description
H3K4me1 Mint-ChIP-seq on T-helper 1 cell male adult (35 years) treated with 1 ?g/mL Interleukin-4 antibody , 30 ng/mL Interleukin-12 subunit alpha , 30 ng/mL Interleukin-12 subunit beta
Treatments
1 μg/mL Interleukin-4 antibody for 36 hours, 30 ng/mL Interleukin-12 subunit alpha (UniProtKB:P29459) for 36 hours, 30 ng/mL Interleukin-12 subunit beta (UniProtKB:P29460) for 36 hours
Nucleic acid type
DNA
Controls

Attribution

ENCODE4 project
Lab
Bradley Bernstein, Broad
Award
UM1HG009390 (Bradley Bernstein, Broad)
Project
ENCODE
External resources
Aliases
bradley-bernstein:Project Element 6582
Date released
June 24, 2021

Isogenic replicates

Isogenic replicate
Technical replicate
Summary
Biosample
Antibody
Library
11Homo sapiens male adult (35 years) T-helper 1 primary cell treated with 1 μg/mL Interleukin-4 antibody for 36 hours, 30 ng/mL Interleukin-12 subunit alpha for 36 hours, 30 ng/mL Interleukin-12 subunit beta for 36 hoursENCBS111UJEENCAB845ARKENCLB569PON
12Homo sapiens male adult (35 years) T-helper 1 primary cell treated with 1 μg/mL Interleukin-4 antibody for 36 hours, 30 ng/mL Interleukin-12 subunit alpha for 36 hours, 30 ng/mL Interleukin-12 subunit beta for 36 hoursENCBS111UJEENCAB845ARKENCLB312VWP